Cargando…

Therapeutic Potential and Molecular Mechanisms of Emblica officinalis Gaertn in Countering Nephrotoxicity in Rats Induced by the Chemotherapeutic Agent Cisplatin

Emblica officinalis Gaertn. belonging to family Euphorbiaceae is commonly known as Indian gooseberry or “Amla” in India. It is used as a ‘rejuvenating herb’ in traditional system of Indian medicine. It has been shown to possess antioxidant, anti-inflammatory and anti-apoptotic effects. Thus, on the...

Descripción completa

Detalles Bibliográficos
Autores principales: Malik, Salma, Suchal, Kapil, Bhatia, Jagriti, Khan, Sana I., Vasisth, Swati, Tomar, Ameesha, Goyal, Sameer, Kumar, Rajeev, Arya, Dharamvir S., Ojha, Shreesh K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045924/
https://www.ncbi.nlm.nih.gov/pubmed/27752245
http://dx.doi.org/10.3389/fphar.2016.00350
_version_ 1782457194809131008
author Malik, Salma
Suchal, Kapil
Bhatia, Jagriti
Khan, Sana I.
Vasisth, Swati
Tomar, Ameesha
Goyal, Sameer
Kumar, Rajeev
Arya, Dharamvir S.
Ojha, Shreesh K.
author_facet Malik, Salma
Suchal, Kapil
Bhatia, Jagriti
Khan, Sana I.
Vasisth, Swati
Tomar, Ameesha
Goyal, Sameer
Kumar, Rajeev
Arya, Dharamvir S.
Ojha, Shreesh K.
author_sort Malik, Salma
collection PubMed
description Emblica officinalis Gaertn. belonging to family Euphorbiaceae is commonly known as Indian gooseberry or “Amla” in India. It is used as a ‘rejuvenating herb’ in traditional system of Indian medicine. It has been shown to possess antioxidant, anti-inflammatory and anti-apoptotic effects. Thus, on the basis of its biological effects, the present study was undertaken to evaluate the protective effect of the dried fruit extract of the E. Officinalis (EO) in cisplatin-induced nephrotoxicity in rats and also to evaluate the mechanism of its nephroprotection. The study was done on male albino Wistar rats. They were divided into six groups (n = 6) viz. control, cisplatin-control, cisplatin and EO (150, 300, and 600 mg/kg; p.o. respectively in different groups) and EO only (600 mg/kg; p.o. only). EO was administered orally to the rats for a period of 10 days and on the 7th day, a single injection of cisplatin (8 mg/kg; i.p.) was administered to the cisplatin-control and EO treatment groups. The rats were sacrificed on the 10th day. Cisplatin-control rats had deranged renal function parameters and the kidney histology confirmed the presence of acute tubular necrosis. Furthermore, there were increased oxidative stress, apoptosis and inflammation along with higher expression of MAPK pathway proteins in the rat kidney from the cisplatin-control group. Contrary to this, EO (600 mg/kg) significantly normalized renal function, bolstered antioxidant status and ameliorated histological alterations. The inflammation and apoptosis were markedly lower in comparison to cisplatin-control rats. Furthermore, EO (600 mg/kg) inhibited MAPK phosphorylation which was instrumental in preserving renal function and morphology. In conclusion, the results of our study demonstrated that EO attenuated cisplatin-induced nephrotoxicity in rats through suppression of MAPK induced inflammation and apoptosis.
format Online
Article
Text
id pubmed-5045924
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-50459242016-10-17 Therapeutic Potential and Molecular Mechanisms of Emblica officinalis Gaertn in Countering Nephrotoxicity in Rats Induced by the Chemotherapeutic Agent Cisplatin Malik, Salma Suchal, Kapil Bhatia, Jagriti Khan, Sana I. Vasisth, Swati Tomar, Ameesha Goyal, Sameer Kumar, Rajeev Arya, Dharamvir S. Ojha, Shreesh K. Front Pharmacol Pharmacology Emblica officinalis Gaertn. belonging to family Euphorbiaceae is commonly known as Indian gooseberry or “Amla” in India. It is used as a ‘rejuvenating herb’ in traditional system of Indian medicine. It has been shown to possess antioxidant, anti-inflammatory and anti-apoptotic effects. Thus, on the basis of its biological effects, the present study was undertaken to evaluate the protective effect of the dried fruit extract of the E. Officinalis (EO) in cisplatin-induced nephrotoxicity in rats and also to evaluate the mechanism of its nephroprotection. The study was done on male albino Wistar rats. They were divided into six groups (n = 6) viz. control, cisplatin-control, cisplatin and EO (150, 300, and 600 mg/kg; p.o. respectively in different groups) and EO only (600 mg/kg; p.o. only). EO was administered orally to the rats for a period of 10 days and on the 7th day, a single injection of cisplatin (8 mg/kg; i.p.) was administered to the cisplatin-control and EO treatment groups. The rats were sacrificed on the 10th day. Cisplatin-control rats had deranged renal function parameters and the kidney histology confirmed the presence of acute tubular necrosis. Furthermore, there were increased oxidative stress, apoptosis and inflammation along with higher expression of MAPK pathway proteins in the rat kidney from the cisplatin-control group. Contrary to this, EO (600 mg/kg) significantly normalized renal function, bolstered antioxidant status and ameliorated histological alterations. The inflammation and apoptosis were markedly lower in comparison to cisplatin-control rats. Furthermore, EO (600 mg/kg) inhibited MAPK phosphorylation which was instrumental in preserving renal function and morphology. In conclusion, the results of our study demonstrated that EO attenuated cisplatin-induced nephrotoxicity in rats through suppression of MAPK induced inflammation and apoptosis. Frontiers Media S.A. 2016-10-03 /pmc/articles/PMC5045924/ /pubmed/27752245 http://dx.doi.org/10.3389/fphar.2016.00350 Text en Copyright © 2016 Malik, Suchal, Bhatia, Khan, Vasisth, Tomar, Goyal, Kumar, Arya and Ojha. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Malik, Salma
Suchal, Kapil
Bhatia, Jagriti
Khan, Sana I.
Vasisth, Swati
Tomar, Ameesha
Goyal, Sameer
Kumar, Rajeev
Arya, Dharamvir S.
Ojha, Shreesh K.
Therapeutic Potential and Molecular Mechanisms of Emblica officinalis Gaertn in Countering Nephrotoxicity in Rats Induced by the Chemotherapeutic Agent Cisplatin
title Therapeutic Potential and Molecular Mechanisms of Emblica officinalis Gaertn in Countering Nephrotoxicity in Rats Induced by the Chemotherapeutic Agent Cisplatin
title_full Therapeutic Potential and Molecular Mechanisms of Emblica officinalis Gaertn in Countering Nephrotoxicity in Rats Induced by the Chemotherapeutic Agent Cisplatin
title_fullStr Therapeutic Potential and Molecular Mechanisms of Emblica officinalis Gaertn in Countering Nephrotoxicity in Rats Induced by the Chemotherapeutic Agent Cisplatin
title_full_unstemmed Therapeutic Potential and Molecular Mechanisms of Emblica officinalis Gaertn in Countering Nephrotoxicity in Rats Induced by the Chemotherapeutic Agent Cisplatin
title_short Therapeutic Potential and Molecular Mechanisms of Emblica officinalis Gaertn in Countering Nephrotoxicity in Rats Induced by the Chemotherapeutic Agent Cisplatin
title_sort therapeutic potential and molecular mechanisms of emblica officinalis gaertn in countering nephrotoxicity in rats induced by the chemotherapeutic agent cisplatin
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045924/
https://www.ncbi.nlm.nih.gov/pubmed/27752245
http://dx.doi.org/10.3389/fphar.2016.00350
work_keys_str_mv AT maliksalma therapeuticpotentialandmolecularmechanismsofemblicaofficinalisgaertnincounteringnephrotoxicityinratsinducedbythechemotherapeuticagentcisplatin
AT suchalkapil therapeuticpotentialandmolecularmechanismsofemblicaofficinalisgaertnincounteringnephrotoxicityinratsinducedbythechemotherapeuticagentcisplatin
AT bhatiajagriti therapeuticpotentialandmolecularmechanismsofemblicaofficinalisgaertnincounteringnephrotoxicityinratsinducedbythechemotherapeuticagentcisplatin
AT khansanai therapeuticpotentialandmolecularmechanismsofemblicaofficinalisgaertnincounteringnephrotoxicityinratsinducedbythechemotherapeuticagentcisplatin
AT vasisthswati therapeuticpotentialandmolecularmechanismsofemblicaofficinalisgaertnincounteringnephrotoxicityinratsinducedbythechemotherapeuticagentcisplatin
AT tomarameesha therapeuticpotentialandmolecularmechanismsofemblicaofficinalisgaertnincounteringnephrotoxicityinratsinducedbythechemotherapeuticagentcisplatin
AT goyalsameer therapeuticpotentialandmolecularmechanismsofemblicaofficinalisgaertnincounteringnephrotoxicityinratsinducedbythechemotherapeuticagentcisplatin
AT kumarrajeev therapeuticpotentialandmolecularmechanismsofemblicaofficinalisgaertnincounteringnephrotoxicityinratsinducedbythechemotherapeuticagentcisplatin
AT aryadharamvirs therapeuticpotentialandmolecularmechanismsofemblicaofficinalisgaertnincounteringnephrotoxicityinratsinducedbythechemotherapeuticagentcisplatin
AT ojhashreeshk therapeuticpotentialandmolecularmechanismsofemblicaofficinalisgaertnincounteringnephrotoxicityinratsinducedbythechemotherapeuticagentcisplatin